APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gonadotropin-releasing Hormone Antagonists

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gonadotropin-releasing Hormone Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026188 pages

Choose your research edition.

Industry ResearchGonadotropin-releasing Hormone Antagonists Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Gonadotropin-releasing Hormone Antagonists Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Gonadotropin-releasing Hormone Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gonadotropin-releasing Hormone Antagonists Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Gonadotropin-releasing Hormone Antagonists Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Gonadotropin-releasing Hormone Antagonists market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gonadotropin-releasing Hormone Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gonadotropin-releasing Hormone Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gonadotropin-releasing Hormone Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gonadotropin-releasing Hormone Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gonadotropin-releasing Hormone Antagonists include Ferring Pharmaceuticals, Kissei, Myovant Sciences, Veru Inc, AstraZeneca, AbbVie, Astellas, Jiangsu Hengrui Medicine Co and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gonadotropin-releasing Hormone Antagonists market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gonadotropin-releasing Hormone Antagonists and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gonadotropin-releasing Hormone Antagonists sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gonadotropin-releasing Hormone Antagonists market size, projected growth trends, production technologies, key applications, and end-use industries.

Gonadotropin-releasing Hormone Antagonists Segment by Company

Ferring Pharmaceuticals

Kissei

Myovant Sciences

Veru Inc

AstraZeneca

AbbVie

Astellas

Jiangsu Hengrui Medicine Co

Takeda

Gonadotropin-releasing Hormone Antagonists Segment by Type

Peptides

Small Molecules

Gonadotropin-releasing Hormone Antagonists Segment by Application

Endometriosis

Uterine Fibroids

Prostate Cancer

Female Infertility

Others

Gonadotropin-releasing Hormone Antagonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gonadotropin-releasing Hormone Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gonadotropin-releasing Hormone Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gonadotropin-releasing Hormone Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gonadotropin-releasing Hormone Antagonists market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gonadotropin-releasing Hormone Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gonadotropin-releasing Hormone Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gonadotropin-releasing Hormone Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gonadotropin-releasing Hormone Antagonists Industry Trends Table 2. Gonadotropin-releasing Hormone Antagonists Industry Drivers Table 3. Gonadotropin-releasing Hormone Antagonists Industry Opportunities and Challenges Table 4. Gonadotropin-releasing Hormone Antagonists Industry Restraints Table 5. Global Gonadotropin-releasing Hormone Antagonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gonadotropin-releasing Hormone Antagonists Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Manufacturers Table 9. Global Gonadotropin-releasing Hormone Antagonists Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Gonadotropin-releasing Hormone Antagonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gonadotropin-releasing Hormone Antagonists Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gonadotropin-releasing Hormone Antagonists Manufacturers, Product Type & Application Table 13. Global Gonadotropin-releasing Hormone Antagonists Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gonadotropin-releasing Hormone Antagonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Peptides Table 17. Major Manufacturers of Small Molecules Table 18. Global Gonadotropin-releasing Hormone Antagonists Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2026) & (W Units) Table 20. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2027-2032) & (W Units) Table 21. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2021-2026) Table 22. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2027-2032) Table 23. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2026) & (W Units) Table 25. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2027-2032) & (W Units) Table 26. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2021-2026) Table 27. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Endometriosis Table 29. Major Manufacturers of Uterine Fibroids Table 30. Major Manufacturers of Prostate Cancer Table 31. Major Manufacturers of Female Infertility Table 32. Major Manufacturers of Others Table 33. Global Gonadotropin-releasing Hormone Antagonists Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2026) & (W Units) Table 35. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2027-2032) & (W Units) Table 36. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2021-2026) Table 37. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2027-2032) Table 38. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 39. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2026) & (W Units) Table 40. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2027-2032) & (W Units) Table 41. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2021-2026) Table 42. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2027-2032) Table 43. Global Gonadotropin-releasing Hormone Antagonists Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2021-2026) & (W Units) Table 45. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2021-2026) Table 46. Global Gonadotropin-releasing Hormone Antagonists Sales Forecasted by Region (2027-2032) & (W Units) Table 47. Global Gonadotropin-releasing Hormone Antagonists Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Gonadotropin-releasing Hormone Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2026) & (W Units) Table 50. North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2027-2032) & (W Units) Table 51. Europe Gonadotropin-releasing Hormone Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2026) & (W Units) Table 53. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2027-2032) & (W Units) Table 54. Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2026) & (W Units) Table 56. Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales by Country (2027-2032) & (W Units) Table 57. South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2026) & (W Units) Table 59. South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2027-2032) & (W Units) Table 60. Global Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2021-2026) Table 64. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2027-2032) Table 65. Ferring Pharmaceuticals Company Information Table 66. Ferring Pharmaceuticals Business Overview Table 67. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 69. Ferring Pharmaceuticals Recent Development Table 70. Kissei Company Information Table 71. Kissei Business Overview Table 72. Kissei Gonadotropin-releasing Hormone Antagonists Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Kissei Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 74. Kissei Recent Development Table 75. Myovant Sciences Company Information Table 76. Myovant Sciences Business Overview Table 77. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 79. Myovant Sciences Recent Development Table 80. Veru Inc Company Information Table 81. Veru Inc Business Overview Table 82. Veru Inc Gonadotropin-releasing Hormone Antagonists Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Veru Inc Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 84. Veru Inc Recent Development Table 85. AstraZeneca Company Information Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 89. AstraZeneca Recent Development Table 90. AbbVie Company Information Table 91. AbbVie Business Overview Table 92. AbbVie Gonadotropin-releasing Hormone Antagonists Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. AbbVie Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 94. AbbVie Recent Development Table 95. Astellas Company Information Table 96. Astellas Business Overview Table 97. Astellas Gonadotropin-releasing Hormone Antagonists Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Astellas Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 99. Astellas Recent Development Table 100. Jiangsu Hengrui Medicine Co Company Information Table 101. Jiangsu Hengrui Medicine Co Business Overview Table 102. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 104. Jiangsu Hengrui Medicine Co Recent Development Table 105. Takeda Company Information Table 106. Takeda Business Overview Table 107. Takeda Gonadotropin-releasing Hormone Antagonists Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Takeda Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 109. Takeda Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Gonadotropin-releasing Hormone Antagonists Distributors List Table 113. Gonadotropin-releasing Hormone Antagonists Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Gonadotropin-releasing Hormone Antagonists Product Image Figure 2. Global Gonadotropin-releasing Hormone Antagonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gonadotropin-releasing Hormone Antagonists Market Size (2021-2032) & (US$ Million) Figure 4. Global Gonadotropin-releasing Hormone Antagonists Sales (2021-2032) & (W Units) Figure 5. Global Gonadotropin-releasing Hormone Antagonists Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Gonadotropin-releasing Hormone Antagonists Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Peptides Image Figure 9. Small Molecules Image Figure 10. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2021-2032) Figure 13. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2021-2032) Figure 16. Endometriosis Image Figure 17. Uterine Fibroids Image Figure 18. Prostate Cancer Image Figure 19. Female Infertility Image Figure 20. Others Image Figure 21. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2021-2032) Figure 24. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2021-2032) Figure 27. North America Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 28. North America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2021-2032) Figure 29. U.S. Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Canada Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Mexico Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2021-2032) Figure 34. Germany Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 35. France Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 36. U.K. Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Italy Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Netherlands Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2021-2032) Figure 41. China Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Japan Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 43. South Korea Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Southeast Asia Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 45. India Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Australia Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2021-2032) Figure 49. Brazil Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South Africa Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Saudi Arabia Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Turkey Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Argentina Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 54. UAE Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Egypt Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Chile Gonadotropin-releasing Hormone Antagonists Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Global Gonadotropin-releasing Hormone Antagonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Figure 60. North America Gonadotropin-releasing Hormone Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Figure 62. Europe Gonadotropin-releasing Hormone Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Gonadotropin-releasing Hormone Antagonists Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Gonadotropin-releasing Hormone Antagonists Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Peptides
  • Small Molecules
Applications
  • Endometriosis
  • Uterine Fibroids
  • Prostate Cancer
  • Female Infertility
  • Others
Companies covered
  • Ferring Pharmaceuticals
  • Kissei
  • Myovant Sciences
  • Veru Inc
  • AstraZeneca
  • AbbVie
  • Astellas
  • Jiangsu Hengrui Medicine Co
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gonadotropin-releasing Hormone Antagonists Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gonadotropin-releasing Hormone Antagonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gonadotropin-releasing Hormone Antagonists Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gonadotropin-releasing Hormone Antagonists Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gonadotropin-releasing Hormone Antagonists Market Dynamics
  1. 2.1 Gonadotropin-releasing Hormone Antagonists Industry Trends
  2. 2.2 Gonadotropin-releasing Hormone Antagonists Industry Drivers
  3. 2.3 Gonadotropin-releasing Hormone Antagonists Industry Opportunities and Challenges
  4. 2.4 Gonadotropin-releasing Hormone Antagonists Industry Restraints
3 Gonadotropin-releasing Hormone Antagonists Market by Manufacturers
  1. 3.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gonadotropin-releasing Hormone Antagonists Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gonadotropin-releasing Hormone Antagonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gonadotropin-releasing Hormone Antagonists Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gonadotropin-releasing Hormone Antagonists Manufacturers, Product Type & Application
  7. 3.7 Global Gonadotropin-releasing Hormone Antagonists Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gonadotropin-releasing Hormone Antagonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gonadotropin-releasing Hormone Antagonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gonadotropin-releasing Hormone Antagonists Tier 1, Tier 2, and Tier 3
4 Gonadotropin-releasing Hormone Antagonists Market by Type
  1. 4.1 Gonadotropin-releasing Hormone Antagonists Type Introduction
  2. 4.1.1 Peptides
  3. 4.1.2 Small Molecules
  4. 4.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Type
  5. 4.2.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2032)
  7. 4.2.3 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2021-2032)
  8. 4.3 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type
  9. 4.3.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2032)
  11. 4.3.3 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2021-2032)
5 Gonadotropin-releasing Hormone Antagonists Market by Application
  1. 5.1 Gonadotropin-releasing Hormone Antagonists Application Introduction
  2. 5.1.1 Endometriosis
  3. 5.1.2 Uterine Fibroids
  4. 5.1.3 Prostate Cancer
  5. 5.1.4 Female Infertility
  6. 5.1.5 Others
  7. 5.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Application
  8. 5.2.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2032)
  10. 5.2.3 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2021-2032)
  11. 5.3 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application
  12. 5.3.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2032)
  14. 5.3.3 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2021-2032)
6 Global Gonadotropin-releasing Hormone Antagonists Sales by Region
  1. 6.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2021-2032)
  3. 6.2.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2021-2026)
  4. 6.2.2 Global Gonadotropin-releasing Hormone Antagonists Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gonadotropin-releasing Hormone Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gonadotropin-releasing Hormone Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region
  1. 7.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region
  2. 7.1.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2021-2026)
  4. 7.1.3 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2027-2032)
  5. 7.1.4 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032)
  8. 7.2.2 North America Gonadotropin-releasing Hormone Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032)
  11. 7.3.2 Europe Gonadotropin-releasing Hormone Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gonadotropin-releasing Hormone Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ferring Pharmaceuticals
  2. 8.1.1 Ferring Pharmaceuticals Company Information
  3. 8.1.2 Ferring Pharmaceuticals Business Overview
  4. 8.1.3 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Portfolio
  6. 8.1.5 Ferring Pharmaceuticals Recent Developments
  7. 8.2 Kissei
  8. 8.2.1 Kissei Company Information
  9. 8.2.2 Kissei Business Overview
  10. 8.2.3 Kissei Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kissei Gonadotropin-releasing Hormone Antagonists Product Portfolio
  12. 8.2.5 Kissei Recent Developments
  13. 8.3 Myovant Sciences
  14. 8.3.1 Myovant Sciences Company Information
  15. 8.3.2 Myovant Sciences Business Overview
  16. 8.3.3 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Portfolio
  18. 8.3.5 Myovant Sciences Recent Developments
  19. 8.4 Veru Inc
  20. 8.4.1 Veru Inc Company Information
  21. 8.4.2 Veru Inc Business Overview
  22. 8.4.3 Veru Inc Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Veru Inc Gonadotropin-releasing Hormone Antagonists Product Portfolio
  24. 8.4.5 Veru Inc Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 AbbVie
  32. 8.6.1 AbbVie Company Information
  33. 8.6.2 AbbVie Business Overview
  34. 8.6.3 AbbVie Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie Gonadotropin-releasing Hormone Antagonists Product Portfolio
  36. 8.6.5 AbbVie Recent Developments
  37. 8.7 Astellas
  38. 8.7.1 Astellas Company Information
  39. 8.7.2 Astellas Business Overview
  40. 8.7.3 Astellas Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Astellas Gonadotropin-releasing Hormone Antagonists Product Portfolio
  42. 8.7.5 Astellas Recent Developments
  43. 8.8 Jiangsu Hengrui Medicine Co
  44. 8.8.1 Jiangsu Hengrui Medicine Co Company Information
  45. 8.8.2 Jiangsu Hengrui Medicine Co Business Overview
  46. 8.8.3 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Portfolio
  48. 8.8.5 Jiangsu Hengrui Medicine Co Recent Developments
  49. 8.9 Takeda
  50. 8.9.1 Takeda Company Information
  51. 8.9.2 Takeda Business Overview
  52. 8.9.3 Takeda Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Takeda Gonadotropin-releasing Hormone Antagonists Product Portfolio
  54. 8.9.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gonadotropin-releasing Hormone Antagonists Value Chain Analysis
  2. 9.1.1 Gonadotropin-releasing Hormone Antagonists Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gonadotropin-releasing Hormone Antagonists Production Mode & Process
  6. 9.2 Gonadotropin-releasing Hormone Antagonists Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gonadotropin-releasing Hormone Antagonists Distributors
  9. 9.2.3 Gonadotropin-releasing Hormone Antagonists Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst